Experiences and psychological distress of fertility treatment and employment by Payne, Nicola et al.
Middlesex University Research Repository
An open access repository of
Middlesex University research
http://eprints.mdx.ac.uk
Payne, Nicola, Seenan, Susan and van den Akker, Olga (2018) Experiences and psychological
distress of fertility treatment and employment. Journal of Psychosomatic Obstetrics &
Gynecology . ISSN 0167-482X (Published online first)
Final accepted version (with author’s formatting)
This version is available at: http://eprints.mdx.ac.uk/24066/
Copyright:
Middlesex University Research Repository makes the University’s research available electronically.
Copyright and moral rights to this work are retained by the author and/or other copyright owners
unless otherwise stated. The work is supplied on the understanding that any use for commercial gain
is strictly forbidden. A copy may be downloaded for personal, non-commercial, research or study
without prior permission and without charge.
Works, including theses and research projects, may not be reproduced in any format or medium, or
extensive quotations taken from them, or their content changed in any way, without first obtaining
permission in writing from the copyright holder(s). They may not be sold or exploited commercially in
any format or medium without the prior written permission of the copyright holder(s).
Full bibliographic details must be given when referring to, or quoting from full items including the
author’s name, the title of the work, publication details where relevant (place, publisher, date), pag-
ination, and for theses or dissertations the awarding institution, the degree type awarded, and the
date of the award.
If you believe that any material held in the repository infringes copyright law, please contact the
Repository Team at Middlesex University via the following email address:
eprints@mdx.ac.uk
The item will be removed from the repository while any claim is being investigated.
See also repository copyright: re-use policy: http://eprints.mdx.ac.uk/policies.html#copy
  
Experiences and psychological distress of fertility treatment and employment 
Accepted for publication in the Journal of Psychosomatic Obstetrics & Gynecology  
 
Nicola Payne1, Susan Seenan2 and Olga van den Akker1 
 
1Department of Psychology, Middlesex University, London, UK 
2Fertility Network UK, London, UK. 
 
 
 
 
Correspondence concerning this article should be addressed to Nicola Payne 
Middlesex University, The Burroughs, London NW4 4BT, UK. Email: n.payne@mdx.ac.uk 
 
 
Acknowledgements 
We wish to thank Emma Hughes for her support with data analysis.  
  
  
2 
Experiences and psychological distress of fertility treatment and employment 
Abstract 
Purpose: This study examined experiences and psychological distress about fertility treatment 
in people combining work and treatment. 
Methods: 563 participants in the UK completed an online survey asking about difficulties in 
combining work and treatment; workplace disclosure, support, absence and policy; and 
psychological distress about treatment. 
Results: Absence from work and perceptions that treatment has an impact on work and career 
prospects were reported by the majority of participants and this was related to the 
psychological distress of treatment. Around three quarters of participants disclosed to their 
employer and colleagues. The key reason for disclosure was needing to ask for absence from 
work and the main reason for non-disclosure was privacy. Workplace policy relating to 
managing fertility treatment and support from colleagues and their employer was related to 
reduced psychological distress but workplace policy was reported by less than one quarter of 
participants. 
Conclusions: Difficulties experienced in combining work and treatment suggest that support 
is needed. Specific workplace policy, guidance for supervisors and flexibility in fertility 
clinic times should help support employees during treatment and reduce psychological 
distress, thereby potentially influencing physical health and treatment outcomes. 
 
Key words: assisted reproduction, infertility, psychological distress, workplace, disclosure, 
support, workplace policy. 
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Introduction 
Latest statistics from the HFEA show that in the UK during 2014, 52,288 women had a total 
of 67,708 cycles of IVF or ICSI and these figures continue to rise [1]. Fertility treatment is a 
physically, psychologically and financially demanding process. Both women and men 
undergoing treatment have been found to experience high levels of distress worldwide, with 
women experiencing more distress than men [2, 3]. Although the evidence is equivocal, the 
distress experienced may itself affect treatment outcomes [4, 5] and psychological support 
may improve outcomes [6], so it is important to understand the difficulties experienced 
during treatment and the conditions that may create psychological distress. While there is 
much research exploring the experience of fertility treatment, there has been limited research 
examining experiences of combining treatment and employment. As the majority of men and 
women of child-bearing age are employed and spend much of their waking lives at work, 
specific difficulties and dilemmas are likely to be encountered. However, to date there has 
been no large-scale survey examining the extent to which combining treatment and work is 
perceived to be problematic. This is the aim of the present study.    
 
A key difficulty in combining work and treatment is the need for time off work for clinic 
appointments. Bouwmans et al. [7] found that women in the Netherlands were absent from 
work for on average 23 hours during a treatment cycle. The main reason for absence reported 
by half the sample was clinic appointments but physical problems (27%) and emotional 
problems alone or combined with physical problems (23%) were also reported. Absence from 
work in women experiencing emotional and/or physical problems rose to on average 41 hours 
per cycle. Thus there is some evidence that absence is a problem but how this is managed is 
less clear, especially as statutory policy is lacking. For example, in the UK fertility care is not 
a statutory right. Time off for clinic appointments and any associated sickness is considered 
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the same as time off for other medical appointments or other sickness absence, although an 
employer must not treat a woman less favourably than a man in a similar situation, since this 
could amount to sex discrimination [8,9]. Once embryo implantation takes place women are 
protected by the Equality Act [10] and if treated unfairly this would be considered pregnancy 
discrimination. The Employment Statutory Code of Practice [8] suggests organizations 
should treat requests for absences for fertility treatment sympathetically and suggests they 
consider procedures in this area. Some organizations have workplace policy in this area but 
this is not normative and policies vary. Examples include 5 days of paid leave a year for 
women, or in rare cases more generous policies of up to 20 days, but fewer days or only 
annual leave for men, [9].  
 
Due to a lack of research, the extent to which workplace policies supporting fertility 
treatment are available across organizations and the impact of these is not known. However, 
research on other workplace policies may serve as a basis for understanding the potential 
impact. For example, in countries, such as the UK, statutory policies exist to support parents 
and carers, as well as absence from work for pre-natal appointments and maternity and 
paternity leave. While workplace culture is not always supportive of expectant and existing 
parents or carers and discrimination has not been eliminated [11], the existence and use of 
policies, that for example involve flexible working, is linked to reduced distress [12 ,13]. 
This link may be mediated by workplace perceptions and experiences. For example, such 
policies are linked to perceptions of reduced conflict between work and non-work life [14] 
(and perceptions of increased job security, satisfaction and commitment [15]), which in turn 
is linked to better mental and physical health outcomes [16,17]. This raises the possibility of 
a similar framework for those undergoing fertility treatment, whereby workplace policy and 
support may help reduce difficulties in combining work and treatment and support job 
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security, thus reducing psychological distress. This is particularly important because theories 
of the stress response suggest that distress (or chronic stress), such as that associated with 
fertility treatment, causes prolonged activation of major systems of the body, such as the 
hypothalamus pituitary-adrenocortical axis, with deleterious mental and physical health 
consequences [18,19]. Indeed, evidence suggests that distress may affect fertility treatment 
outcomes [4,5]. It may also influence treatment outcomes indirectly via drop-out from 
treatment or using unhealthy behaviours to cope [20]. Thus, if workplace policy and support 
reduce distress, perhaps by lessening conflict between work and fertility treatment, this has 
the potential to reduce the likelihood of mental ill health and the chances of an unsuccessful 
treatment outcome. 
 
In order to use policies to manage absence or to seek workplace support, employees have to 
disclose. However, the lack of statutory policy and thus legal protection for those having 
treatment may undermine the likelihood of disclosure. In Denmark, Martins et al. [21] found 
that 86% of women and men disclosed to close colleagues and 48% to distant colleagues. 
However, in the USA Finamore et al. [22] found that 57% of the employed women they 
surveyed did not disclose to their employer due to their or their partner’s privacy, career 
concerns, not wanting special treatment and embarrassment. Among the 43% who disclosed, 
the reasons were needing absence from work, having a good relationship with their employer, 
having nothing to hide and needing extra support. There was some evidence of an association 
between disclosure and number of days off work but there was no association between 
disclosure and stress levels. Qualitative studies in the UK [23] and New Zealand [24] 
confirmed concerns about disclosure in the workplace included the personal nature of 
treatment and career prospects. Motives for disclosure included feeling it was necessary and 
shared workplace values, experiences and friendships. However, while there is some research 
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on reasons for workplace disclose, little is known about the extent of support that is 
subsequently received and the perceived impact of this.  
 
Furthermore, little research has examined the experience of combining work and treatment 
more broadly. Domar et al. [25] found that 24% of their sample of women across four 
European countries reported that work interfered with treatment and a qualitative study of 32 
women in the UK [26] found that women experienced bi-directional conflict between the 
demands of work and both the time and emotional demands of treatment. This was influenced 
by the extent to which they shifted their identity and priorities away from career to becoming 
a mother during treatment (a finding supported by Walker [24]). There was also evidence that 
conflict may worsen with more cycles of treatment and that workplace support and job 
flexibility were crucial for managing conflict. While this qualitative research [24,26] provides 
some in depth insights, it involved only a small number of women. To date, there has been no 
large-scale quantitative research examining the extent of these experiences and whether, for 
example, difficulties in combining work and treatment worsen with more cycles of treatment 
or are linked to levels of psychological distress. This is the contribution of the present study. 
 
In summary, this study reports the findings of a large survey in the UK examining 
experiences and perceptions of combining treatment and work and the extent to which this is 
perceived to be problematic and linked to psychological distress. Due to the lack of research 
in this area, the study aimed to describe the problem and provide a background and basis for 
future more complex research. More specifically, the study aimed to examine: 
 Absences from work and the existence of relevant policies. It was predicted that: 
o Existence of policy would be related to absence from work 
o Absence would be related to increased psychological distress of treatment 
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o Existence of policy would be related to reduced psychological distress of 
treatment  
 Disclosure and perceptions of support. It was predicted that: 
o Disclosure and perceptions of support would be related to absence from work 
o Disclosure and perceptions of support would be related to reduced 
psychological distress of treatment 
 The perceived impact of work on fertility treatment and of treatment on work and 
career prospects. It was predicted that:  
o Perceived bi-directional impacts of work and treatment would be related to 
more cycles of treatment 
o Perceived bi-directional impacts of work and treatment would be related to 
absence from work  
o Perceived bi-directional impacts of work and treatment would be related to 
increased psychological distress of treatment 
 
Materials and Methods 
Participants 
The research reported in this paper was part of a larger online survey of the impact of 
infertility and fertility treatment in the UK. The research was approved by the authors’ 
University Psychology Department research ethics committee. Participants were recruited by 
Fertility Network UK through their social media, website, digital magazine and at events, and 
also shared with other professional organisations, corporate partners, clinics, and online 
support networks such as FertilityFriends. As is common with online surveys [27], it is not 
possible to know how many participants the survey reached, so a response rate is not 
reported, but 769 participants completed the larger survey and this paper reports on a sample 
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of 563 who were employed while having fertility treatment. 98% of the sample were women, 
93% were in a heterosexual relationship and 95% described themselves as white. The average 
age of participants when they started treatment was 32.93 years (SD = 4.72) and the average 
number of treatment cycles received was 2.62 (SD = 2.23). While this sample is not 
representative of the UK population, it is similar to other samples in online research on 
infertility and fertility treatment, with participants tending to be white, middle class, 
educated, professional, older and in cohabiting relationships [28] and predominately women 
[5].   
 
The survey 
The larger survey covered demographic and treatment information, funding for treatment, 
support for fertility problems and treatment, and the impact of fertility problems and 
treatment on relationships and psychological distress. The psychological distress of treatment 
was measured by 18 items including suicidal feelings, depression, isolation, frustration, anger 
and guilt based on Kerr et al. [29]. Participants were asked the extent to which they had 
experienced each item in relation to their fertility problems and treatment. Response options 
ranged from 1 (not at all) to 5 (all of the time). Responses to the items were summed to form 
an overall measure of distress related to treatment, with possible scores ranging from 18 to 
90. This measure was reliable ( = .94; M = 65.11, SD = 14.04).  
 
The final section of the survey covered whether participants reduced their hours or left their 
job during treatment and questions about the effect of treatment on the job (e.g. lack of 
concentration), fears of treatment affecting career prospects, effects of treatment on career, 
and effects of the job on treatment (e.g. hard to go to appointments) (all with response 
options: yes definitely, yes a bit, not sure and no). Participants were also asked about the 
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amount of time taken off work, what policies or practices they used to take time off, and 
whether their workplace had a specific policy for people having fertility treatment (with 
response options: yes, not sure and no). They were asked whether they disclosed to their 
employer and colleagues and, if they disclosed, whether they received support from their 
employer and colleagues (with response options: a great deal, a bit and none). Finally, they 
were asked about reasons for disclosure or non-disclosure to their employer, and whether 
their employer would benefit from education to help them understand the needs of people 
having treatment (with response options: yes, not sure and no). The survey is available from 
the authors upon request.   
 
Data analysis 
Frequency counts were calculated for categorical variables and means and standard 
deviations for continuous variables. Bivariate analyses were conducted using ANOVA to 
examine group differences where one variable was categorical and the other continuous, such 
as whether there was a difference in levels of treatment distress between people who did and 
not did disclose. Pearson’s correlations were used where both variables were continuous, 
such as whether there was a relationship between absence from work and levels of treatment 
distress. Finally, a multiple regression analysis was used to examine the predictors of distress.  
 
Results 
Absence from work and policy 
The average number of days taken off work during a treatment cycle was 8.74 (SD 9.32). 
50% of participants took up to a week off work, 24% took up to two weeks, 15% took up to 
three weeks, 3% took a month and 8% took more than this and in some cases up to several 
months. Taking more days off was associated with greater psychological distress (r = .14, p = 
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.002). Absence from work for treatment was managed in various ways, as shown in Figure I. 
‘Other’ methods include special leave, swapping shifts or reducing hours or quitting work.  
 
Figure I near here 
 
23% of participants reported their workplace had some policy relating to treatment (19% 
were not sure and 58% said it did not). The available policies varied greatly. In some cases 
policies stated that IVF is elective so no absence from work was allowed. In other cases the 
policies were vague or left decisions to the discretion of the line manager. Some policies 
allowed a specific number of (paid or unpaid) days of absence (generally between 2 and 10 
days) but often restricted the number of treatment cycles that would be supported (generally 
between 1 and 3). As shown at the top of table 1, levels of psychological distress (but not 
absences from work) were lower among those who reported the existence of policy compared 
to those who reported no policy.  
 
Table 1 near here 
 
Disclosure and support 
74% of participants disclosed to at least some colleagues. Of those who disclosed 35% 
received a great deal of support, 47% received a bit of support and 18% received no support. 
72% disclosed to their employer. Of those who disclosed 42% received a great deal of 
support, 48% received a bit of support and 10% received no support. As shown in Table 1, 
those who disclosed to their employer and colleagues had more days off (but did not report 
lower levels of psychological distress) and those who received the most employer and 
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colleague support reported the lowest levels of psychological distress (but did not report more 
absence from work).  
 
Reasons for non-disclosure to their employer are shown in Figure II. ‘Other’ reasons include 
wanting to maintain some normality, not wanting advice and sympathy, and knowing their 
organisation would not be supportive/did not have an IVF policy. Reasons for disclosure to 
their employer are shown in Figure III. ‘Other’ reasons include having to explain the amount 
of sick leave taken, being unable to do an aspect of the job (due to e.g. safety) and knowing 
the organisation had IVF policy.  
 
More than half of participants (60%) reported their employer would benefit from 
education/support to help them better understand the needs of employees having treatment 
(20% were not sure and 21% felt this was not necessary), suggesting that employers were 
generally seen as unaware of the unique needs of employees undergoing fertility treatment. 
 
Figures II and III near here 
 
Combining work and treatment 
Fifty-eight percent of participants reported work affected their treatment ‘definitely’ or ‘a bit’ 
(e.g. it was difficult to make clinic appointments) and 87% reported treatment affected their 
work (e.g. it was difficult to concentrate). 51% were concerned it would affect their career 
prospects and 35% felt it actually affected their career. Furthermore, 13% reduced their hours 
and 6% left their job due to treatment. As shown in Figures IV and V, those who reported 
work affected treatment and that treatment affected work, career prospects and had actually 
affected their career reported greater psychological distress (F = 4.76, p = .003; F = 26.38, p 
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< .001; F = 11.95, p <.001; F = 6.76, p < .001 respectively) and had more cycles of treatment 
(F = 2.70, p = .04; F = 4.98, p = .002; F = 3.91, p = .009; F = 4.86, p < .001 respectively) than 
those who did not think there was an affect or were not sure. Additionally, those who 
reported that treatment affected work reported more absence from work (F = 2.85, p = .04). 
 
Figures IV and V near here  
 
Finally, a multiple linear regression analysis was conducted to predict the psychological 
distress of treatment from the seven predictors that were significant in the analyses discussed 
so far: perceptions that work affected treatment and that treatment affected work, career 
prospects and their career, employer and colleague support and number of days of absence 
from work. As the first six of these variables are categorical, they were dummy coded. After 
controlling for the the number of treatment cycles received, 18% of the variance in treatment 
distress was explained (R2 = .18, F = 4.74, p < .001). Perceptions that work definitely 
affected treatment (ß = .54, p <.001) and affected treatment a bit (ß = .36, p <.001) compared 
to perceptions that work did not affect treatment were the only significant predictors of 
psychological distress. 
   
Discussion 
This study explored the experiences of people combining work and fertility treatment. More 
than half of the participants reported that work affected their treatment, but the impact of 
treatment on work was worse; the vast majority of participants felt that having treatment 
affected their day-to-day work, half were concerned that treatment would affect their career 
prospects, one third felt their career was actually damaged as a result, and one fifth had to 
reduce their work hours or quit their job. These concerns increased with more cycles of 
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treatment and were all related to greater levels of psychological distress about treatment. This 
supports a qualitative study [26] which suggests that both the time demands of treatment and 
the strain of treatment conflict with the demands of work, with difficulties relating to ‘body 
time’ (that is, waiting for when the body is ready for egg collection) further compounding the 
unpredictability of planning absences from work. Furthermore, bodily and associated 
emotional symptoms must also be managed in the workplace to conform to gendered ideal 
worker norms of prioritizing work over personal life and not bringing emotions to work [11].  
 
Difficulties in combining day-to-day work and treatment were also related to greater absence 
from work. The average number of days of absence from work during a treatment cycle 
(8.74) was significantly more than the average 23 hours reported by Bouwmans et al. [7]. 
However, Bouwmans et al. also reported an average of 41 hours of absence for those 
experiencing greater emotional and physical problems relating to treatment and half of their 
sample reported these problems as the main reason for their absence. In the present study, 
more days of absence were associated with greater psychological distress about treatment, so 
emotional problems associated with treatment are likely to be part of the explanation. 
However, physical problems such as side-effects or complications of treatment are also likely 
to be linked to absences from work and future research should examine specific reasons for 
absences. Not only do physical problems such as side-effects or complications of treatment 
increase psychological distress and treatment drop-out [30] but distress in turn may 
exacerbate physical problems. Thus emotional and physical problems associated with 
treatment interact and are likely to be compounded by difficulties of combining work and 
treatment and associated job insecurity. 
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While the impact of treatment on work and career was the biggest concern for participants 
(supported by the results of the multiple regression analysis), more than half also reported 
that work affected their treatment (which is almost twice as many as reported by Domar et al. 
[25]) and this was related to greater psychological distress about treatment. Payne et al. [26] 
found that women undergoing fertility treatment felt that work interfered with treatment by 
affecting their ability to make clinic appointments and focus on treatment. They also feared 
that work demands would undermine treatment outcomes; once again emphasizing the 
potential psychosomatic implications. Since there is evidence to support a link between 
distress and treatment outcomes [4, 5], employer support and understanding to enable 
employees to make treatment a priority, while also maintaining their career trajectory, is 
crucial. However, only one quarter of participants reported the existence of workplace policy 
and less than half of the participants received good support from their employer (although 
90% received at least some support). Workplace policy and support were linked to reduced 
psychological distress about treatment, which highlights the importance of both. Payne et al. 
[26] also highlight the importance of line manager support, especially if more absence from 
work is needed during a cycle and if many cycles of treatment are required. However, in 
order to seek support it is necessary to disclose. In the present study 72% of participants 
disclosed to their employer, which is more than the 43% reported by Finamore et al [22], 
although the main reasons for disclosing (or not) were similar. Although disclosure was not 
related to reduced psychological distress about treatment, the main reasons for non-disclose 
were a desire for privacy and the fear that their employer would not understand. Similarly to 
Finamore et al. [22], disclosure was related to more absence from work. 
 
There are a number of factors that were not explored in the present study that may influence 
the experience of combining work and treatment. In particular, identity centrality in relation 
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to career and to becoming a parent may shift from the former to the latter during treatment 
[24,26]. For some women the drive to achieve parenthood may lead them to forgo their 
career. In contrast, for other women it may be crucial to maintain their career in case 
treatment is unsuccessful, so work may provide a focus and an important role in maintaining 
self-identity (24,26). Especially for these employees, damage to career prospects may be a 
particular concern.  
 
The influence of factors outside of work should also be taken into account in future research. 
For example, being able to attend a local clinic that offers out of hours appointments, and 
benefiting from a high level of support outside of work, especially from a partner, may also 
help reduce time off work and conflicts between work and treatment. Greater social support 
is linked to better mental health in involuntary childless women [31] and the benefits of 
psychological support are also well recognized [6]. However, the fears associated with 
disclosure of treatment to those outside of the immediate personal network, as well as 
feelings of psychological distress, may be compounded in employed men and women, 
making them more vulnerable to the potential impacts of distress on treatment outcomes [4,5] 
and increasing their need for psychological support. 
 
Overall the findings suggest that workplace policy is needed. This may reduce the obstacles 
of disclosing the personal in the public domain of work and reduce psychological distress of 
treatment (as suggested by the findings of this study). This may in turn have implications for 
physical health as evidence suggests that psychological distress may affect fertility treatment 
outcomes directly [4] or indirectly [20], as well as physical health more generally [32]. 
Workplace policy should incorporate flexibility, so that, for example, time can be made up 
later or shifts swapped. Guidance for supervisors, who may have limited understanding of the 
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needs of someone having treatment should also be incorporated. Indeed, in the present study 
fears that employers would not understand was the second most commonly reported reason 
for non-disclosure and more than half felt that their employer would benefit from guidance. 
Ideally this would be combined with clinical practice changes in flexibility of clinic 
appointments to allow at least some of these to take place outside of working hours. This 
would help reduce the amount of absence needed and may also lessen the need for workplace 
disclosure. Finally, psychological intervention to support those having fertility treatment is 
needed and should incorporate discussion of work-related difficulties and dilemmas.   
 
There are some limitations to this study which should be considered in planning future 
research. This self-selected sample was limited in terms of diversity, thus limiting the 
generalizability of the findings. The focus on the UK and the lack of ethnic, and likely lack of 
socioeconomic diversity (although this was not measured) in the sample means that differing 
cultural and socioeconomic attitudes to infertility or childlessness were not included. For 
example, in some countries childlessness is viewed as a personal failure and parenthood is 
considered a necessary part of adulthood and especially womanhood [33]. The focus on one 
country or a sample lacking in diversity is unfortunately common to much research on 
infertile populations [e.g. 5,28]. Therefore, future research should aim to examine the 
experiences of a diverse range of participants. Furthermore, as many participants were asked 
to retrospectively recall their experiences, which could have led to recall bias, it would be 
useful to adopt a longitudinal approach during the course of treatment and beyond, to gain 
greater understanding of the experience of combining work and treatment as it unfolds. This 
would also enable examination of a model predicting psychological distress, physical health, 
and treatment complications and outcomes. The findings of this study suggest that such 
research would be a worthwhile endeavor. 
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In conclusion, research on combining employment and fertility treatment is limited but the 
findings of the present study suggest that psychological distress is compounded by the effects 
of work and provide a basis for future research. Reports that treatment affects work, and 
career and vice versa, and the subsequent link to psychological distress, suggest that 
workplace policy, guidance for supervisors, flexibility in fertility clinic times and 
psychological support are needed to support employees having fertility treatment. If such 
supports help to reduce psychological distress and conflicts between work and treatment, this 
has implications for employee retention, and may have implications for physical health and 
successful treatment outcomes or at the very least for an improved treatment experience. 
 
References 
1. Human Fertilisation and Embryology Authority. Fertility Treatment in 2014. Trends and 
Figures. 2016. 
http://www.hfea.gov.uk/docs/HFEA_Fertility_treatment_Trends_and_figures_2014.pdf . 
Accessed 25 October 2017. 
2. Greil AL, Slauson-Blevins K, McQuillan J. The experience of infertility: A review of 
recent literature. Sociol Health Illn 2010;32(1):140-162. 
3. Ying L, Har Wu L, Yuen Loke A. Gender differences in emotional reactions to in vitro 
fertilization treatment: a systematic review. J Assist Reprod Genet 2016;33(2):167-179. 
4. Matthiesen SM, Frederiksen Y, Ingerslev HJ, Zachariae R. Stress, distress, and outcomes 
of assisted reproductive technology (ART): a meta-analysis. Hum Reprod 2011;26(10):2763-
76.  
5. Purewal S, Chapman SCE, van den Akker OBA. A systematic review and meta-analysis of 
psychological predictors of successful assisted reproductive technologies. BMC Res Notes 
  
18 
2017;10:711.  
6. Frederiksen Y, Farver-Vestergaard I, Grønhøj Skovgård N, Ingerslev H, Zachariae R. 
Efficacy of psychosocial interventions for psychological and pregnancy outcomes in infertile 
women and men: a systematic review and meta-analysis. BMJ Open 2015:e006592 
7. Bouwmans CA, Lintsen BA, Al M, Verhaak CM, Eijkemans RJ, Habbema JD, Braat DD, 
Hakkaart-Van Roijen L. Absence from work and emotional stress in women undergoing IVF 
or ICSI: an analysis of IVF-related absence from work in women and the contribution of 
general and emotional factors. Acta Obstet Gynecol Scand 2008;87(11):1169-75. 
8. Employment Statutory Code of Practice. Equality and Human Rights Commission. 2011. 
https://www.equalityhumanrights.com/sites/default/files/employercode.pdf Accessed 28 
October 2017 
9. Schindler M. Fertility Treatment and Employment. 2014. 
https://www.withersworldwide.com/en-gb/fertility-treatment-and-
employment  Accessed 28 October 2017 
10. Equality Act. 2010. 
https://www.legislation.gov.uk/ukpga/2010/15/pdfs/ukpga_20100015_en.pdf Accessed 28 
October 2017 
11. Stumbitz B, Lewis S, Rouse J. Maternity management in SMEs: A transdisciplinary 
review and research agenda. Int J Manag Rev 2017. Online first. 
12. Moen P, Kelly EL, Tranby E, Huang Q. Changing Work, Changing Health: Can Real 
Work-Time Flexibility Promote Health Behaviors and Well-Being? J Health Soc Behav 
2011;52(4):404-429. 
13. Chesley N, Moen P. When Workers Care: Dual-Earner Couples' Caregiving Strategies, 
Benefit Use, and Psychological Well-Being. Am Behav Sci 2006;49(9): 1248-1269. 
14. Feeney MK, Stritch JM. Family-friendly policies, gender, and work-life balance in the 
  
19 
public sector. Rev Public Pers Adm 2017. Online first. 
15. Butts MM, Casper WJ, Yang TS. How important are work-family support policies? A 
meta-analytic investigation of their effects on employee outcomes. J Appl Psychol 
2013;98(1):1-25. 
16. Berkman LF, Liu SY, Hammer L, Moen P, Klein LC, Kelly E, Fay M, Davis K, Durham 
M, Karuntzos G, Buxton OM. Work–family conflict, cardiometabolic risk, and sleep duration 
in nursing employees. J Occup Health Psychol 2015;20(4):420-433. 
17. Cooklin AR, Dinh H, Strazdins L, Westrupp E, Leach LS, Nicholson JM. Change and 
stability in work–family conflict and mothers' and fathers' mental health: Longitudinal 
evidence from an Australian cohort. Soc Sci Med 2016;155:24-34. 
18. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, Scheimann J, 
Myers B. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr 
Physiol 2016;6(2):603-621. 
19. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 
2009;5(7):374-381. 
20. Verhaak CM, Lintsen AME, Evers AWM, Braat DDM. Who is at risk of emotional 
problems and how do you know? Screening women going for IVF treatment. Hum Reprod 
2010;2(5):1234-1240. 
21. Martins M, Peterson B, Costa P, Costa M, Lund R, Schmidt L. Interactive effects of 
social support and disclosure on fertility-related stress. J Soc Pers Relatsh 2013;30(4):371-
388. 
22. Finamore PS, Seifer DB, Ananth CV and Leiblum SR. Social concerns of women 
undergoing infertility treatment. Fertil Steril 2007;88(4):817-821. 
23. van den Akker OBA, Payne N, Lewis S. Catch-22? Disclosing Assisted Reproductive 
Technology treatment in the workplace. Int J Workplace Health Manag 2017;10(5);364-375. 
  
20 
24 Walker S. The experience of combining fertility treatment and paid employment. 
Women’s Narratives. 
http://aut.researchgateway.ac.nz/bitstream/handle/10292/4788/WalkerS.pdf?sequence=3  
Accessed 28 October 2017 
25. Domar A, Gordon K, Garcia-Velasco J, La Marca A. Understanding the 
perceptions of and emotional barriers to infertility treatment: a survey in four 
European countries. Hum Reprod 2012;27(4):1073-1079. 
26. Payne N, Lewis S, Constantinou C, van den Akker OBA. Experiences of combining work 
and fertility treatment; personal meanings and conflicts. Submitted to J Manage Psychol. 
27 van den Akker OBA, Crawshaw MA, Blyth ED, Frith LJ. Expectations and experiences of 
gamete donors and donor-conceived adults searching for genetic relatives using DNA linking 
through a voluntary register Hum Reprod 2015;30(1):111–121. 
28 Datta J, Palmer MJ, Tanton C, Gibson LJ. Prevalence of infertility and help seeking 
among 15 000 women and men. Hum Reprod 2016;31(9):2108-2118. 
29. Kerr J, Brown C, Balen AH. The experiences of couples who have had infertility 
treatment in the United Kingdom: results of a survey performed in 1997. Hum Reprod 
1999;14(4):934-38. 
30. Gameiro S, Boivin J, Peronace L, Verhaak CM. Why do patients discontinue fertility 
treatment? A systematic review of reasons and predictors of discontinuation in fertility 
treatment. Hum Reprod Update 2012;18(6):652-669. 
31. Batool SS, de Visser R. Psychosocial and contextual determinants of health among 
infertile women: a cross cultural study. Psychol Health Med 2014;19(6):673-679. 
32. Salovey P, Rothman AJ, Detweller JB, Steward WT. Emotional states and physical 
health. Am Psychol 2000;55(1):110-121. 
33. van den Akker OBA. Reproductive Health Psychology. 2012. Wiley-Blackwell. 
  
21 
Table 1: The association between policy and psychological distress, disclosure and 
psychological distress, and support and days off work 
 
Variable 
 
M (SD) Psychological distress 
 
F 
 
p 
Workplace policy No policy Not sure Policy   
 66.12 (14.11) 65.04 (13.25) 61.95 (14.93) 3.53 .03 
Employer support No support A bit of 
support 
A great deal   
 69.22 (14.61) 66.56 (13.25) 62.43 (13.79) 5.78 .003 
Colleague support No support A bit of 
support 
A great deal   
 71.57 (12.06) 65.21 (12.83) 63.08 (14.76) 10.32 < .001 
    
 M (SD) Number of days off work   
Disclosed to employer Disclosure Non-disclosure    
 9.82 (5.23) 5.89 (4.29)  17.92 <.001 
Disclosed to colleagues Disclosure Non-disclosure    
 9.34 (9.73) 7.04 (7.77)  5.85 .02 
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Figure I: Methods used to manage absence from work 
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Figure II: Reasons for non-disclosure to an employer 
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Figure III: Reasons for disclosure to an employer 
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Figure IV: The association between average levels of psychological distress and experience 
of work affecting treatment/treatment affecting work.  
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Figure V: The association between number of cycles of treatment and experience of work 
affecting treatment/treatment affecting work. 
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